Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This specific combination of metabolic cofactors—comprising the resveratrol precursor **piceid**, the amino acids **glycine** and **glutamine**, the glutathione precursor **N-acetyl cysteine (NAC)**, and the micronutrients **zinc** and **vitamin B6**—is designed to support cellular energy metabolism and antioxidant capacity. The formulation targets multiple pathways involved in mitochondrial function and oxidative stress management. Piceid (resveratrol-3-O-beta-D-glucoside) acts as a sirtuin activator and antioxidant; glycine and NAC are rate-limiting precursors for glutathione synthesis; glutamine supports the tricarboxylic acid (TCA) cycle and nitrogen metabolism; while zinc and vitamin B6 serve as essential enzymatic cofactors. This combination has been investigated in clinical research settings, particularly in studies exploring metabolic activators for conditions characterized by mitochondrial dysfunction or metabolic stress, such as aging-related decline or viral infections.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on piceid + glycine + glutamine + N-acetyl cysteine + zinc + vitamin B6.